Signal amplification method of miRNA and application thereof
By combining lock probes and rolling ring amplification technology, the strong combination of A base and AuE is used to achieve efficient detection of miRNA-21, solving the problems of low detection sensitivity and time-consuming and labor-consuming in the prior art. A highly effective miRNA detection method suitable for clinical use is provided.
Patent Information
- Application Number
- CN202411347540.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-26
- Publication Date
- 2024-12-06
AI Technical Summary
The existing miRNA detection methods have problems such as low sensitivity, time-consuming and labor-consuming, cross-reaction and interference, which are difficult to meet the needs of clinical testing, especially the extremely low content of circulating miRNAs in the blood, resulting in increased detection difficulty.
A super sensitive electrochemical sensing technology was developed to hybridize to miRNA using lock probes, and through strong binding of rolling ring amplification technology and A base-AuE, it can achieve efficient detection of miRNA-21, including designing T-rich The base locking probe, T4 DNA Ligase and phi29 DNA Polymerase trigger the RCA reaction, producing periodic repetitive long-chain DNA products, and combining with gold electrodes for signal amplification.
Achieve high sensitivity detection of low-abundance miRNA-21, with higher working efficiency and precision, can be detected under isothermal conditions, simplifies the requirements of instruments and equipment, better than previous methods, and can identify single bases Mutant RNA sequence and suitable for the detection of complex biological samples.
Smart Images

Figure CN119082269A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biological detection, and relates to the application of an electrochemical biosensor constructed based on a target-triggered rolling circle amplification signal amplification strategy in microRNAs detection. Background Art
[0002] MicroRNAs (miRNAs) are a class of non-coding RNAs with a length of 18-25 bases. Studies have shown that some miRNAs are involved in the regulation of cell cycle and lung cancer growth, including apoptosis, angiogenesis, invasion and metastasis, by targeting different or similar genes. Therefore, the development of quantitative analysis methods with high sensitivity and specificity to detect the types and expression levels of miRNAs in body fluids is of great significance for the early diagnosis of lung cancer, pathological analysis, and prognostic evaluation. Northern blot analysis, RT-PCR, and microarray chips are the most common miRNA detection methods, but they have low sensitivity, cross-reaction or interference, and are time-consuming and labor-intensive, which limits their application in clinical practice. There is an urgent need to develop a fast and simple miRNA detection method.
[0003] Researchers have developed various new miRNAs detection methods based on electrochemical sensing technology. For example, Kimura-Suda H's research group confirmed that there is an adsorption affinity between nucleotide sequences and AuE, and the trend is: A base>C base≥G base>T base. Based on this study, Koo KM's research group extended the target miRNAs end with poly (A) sequence to promote adsorption between the miRNA-AuE surface, which is convenient for subsequent research. This sensor can detect miRNAs with high sensitivity, and its detection limit is 10fM. However, due to the extremely low content of circulating miRNAs in the blood, this sensor still cannot meet the actual needs of clinical detection. Summary of the invention
[0004] To address the above shortcomings, the present invention has developed a novel electrochemical sensing technology for ultra-sensitive detection of miRNA (such as miRNA-21). Specifically,
[0005] The first aspect of the present invention provides a padlock probe for miRNA detection, the probe comprising two end regions and a middle region; the two end regions are a 5' end region and a 3' end region, the 5' end region comprises a recognition sequence 1 of the target miRNA to be detected, and the 3' end region comprises a recognition sequence 2 of the target miRNA to be detected; the middle region is rich in T bases.
[0006] In certain embodiments, the recognition sequence 1 hybridizes with segment A of the miRNA to be detected, and the recognition sequence 2 hybridizes with segment B of the miRNA to be detected; the hybridization is complete hybridization or partial hybridization; and the segments A and B do not overlap.
[0007] In certain embodiments, the 3' end of segment A is closely connected to the 5' end of segment B or is separated by less than 5 nucleotides, or the 3' end of segment B is closely connected to the 5' end of segment A or is separated by less than 5 nucleotides; the separation of less than 5 nucleotides means a separation of 4, 3, 2, 1 or 0 nucleotides; preferably, a separation of 0 nucleotides.
[0008] In certain embodiments, the recognition sequence can hybridize with the miRNA to be detected so that the two ends of the probe are close together.
[0009] In some embodiments, the lengths of the recognition sequence 1 and the recognition sequence 2 are 8-14 bp respectively; the lengths of the recognition sequence 1 and the recognition sequence 2 are the same or different; preferably, the lengths of the recognition sequence 1 and the recognition sequence 2 are 11 bp respectively.
[0010] In certain embodiments, the middle region contains 6-15 T bases; preferably, contains 10 T bases.
[0011] In certain embodiments, the miRNA is miRNA-21.
[0012] In certain embodiments, the sequence of the probe is shown in SEQ ID NO:9.
[0013] The second aspect of the present invention provides the use of the padlock probe according to the first aspect of the present invention in the preparation of a cancer diagnostic product; preferably, the cancer has abnormal miRNA expression.
[0014] In certain embodiments, the cancer is lung cancer and the miRNA is miRNA-21.
[0015] The third aspect of the present invention provides a miRNA detection kit, which comprises the padlock probe described in the first aspect of the present invention.
[0016] In certain embodiments, the kit further comprises a component selected from DNA ligase, DNA polymerase, dNTPs and miRNA; preferably, the DNA ligase is T4 DNA Ligase, the DNA polymerase is phi29 DNA Polymerase, and the miRNA is miRNA-21.
[0017] In certain embodiments, the detection comprises the following steps: 1) hybridizing the padlock probe with the miRNA to be detected so that the two ends of the probe are close together; 2) using T4 DNA Ligase to connect the two ends of the probe into a circular structure to form a circular template for the RCA reaction; 3) in the presence of phi29 DNA Polymerase and dNTPs, the miRNA to be detected is used as a primer to continuously trigger the RCA reaction, thereby generating a periodically repeated long-chain DNA product; 4) utilizing the strong binding force between the A base in the long-chain DNA product and the gold electrode (AuE) to achieve efficient assembly of the RCA product on the AuE. The presence of the RCA product hinders the electron transfer on the AuE surface, causing the electrochemical signal to attenuate; 5) monitoring the attenuation of the electrochemical signal by differential pulse voltammetry (DPV) to indicate the concentration of the miRNA to be detected.
[0018] The fourth aspect of the present invention provides a method for amplifying a miRNA signal, comprising the following steps: 1) hybridizing the padlock probe described in the first aspect of the present invention with the miRNA so that the two ends of the probe are close together; 2) using T4 DNA Ligase to connect the two ends of the probe into a circular structure to form a circular template for the RCA reaction; 3) in the presence of phi29 DNA Polymerase and dNTPs, the miRNA acts as a primer to continuously trigger the RCA reaction, thereby generating a periodically repeated long-chain DNA product to achieve signal amplification.
[0019] The fifth aspect of the present invention provides an electrochemical biosensor for detecting miRNAs, wherein the sensor comprises a miRNA to be detected, a recognition element, a receptor, a transducer, and an electrochemical workstation; the recognition element is a lock probe as described in any one of the claims; the receptor is a gold electrode; and the transducer is a computer.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] The present invention combines rolling circle amplification technology with the strong binding effect of A base-AuE for the first time, and develops a new type of electrochemical sensor for ultra-sensitive detection of miRNA (such as miRNA-21). The structure or composition of the sensor is: a substance to be tested (such as miRNA-21), a recognition element (lock probe), a receptor (gold electrode), a transducer (computer), and an electrochemical workstation. The sensor: 1) uses amplification technology to enrich the low-abundance target miRNA-21 to enhance the change of the electrochemical response signal; 2) a specific lock probe rich in poly-T is used for rolling circle amplification reaction, which gives the sensor excellent base recognition ability; 3) has higher working efficiency and higher precision, and can detect the target more accurately.
[0022] The sensor can complete the assembly of the product without thiol modification, avoiding the complexity of functional modification of the electrode. Compared with traditional PCR technology, this method has obvious advantages such as being able to be carried out under isothermal conditions (without cumbersome heating and cooling processes) and having lower requirements for instruments and equipment. In this study, the optimal concentration of the padlock probe was determined to be 100nM, the optimal time for RCA product assembly on the electrode was 20min, the optimal reaction time of T4 DNA Ligase was 0.5h, and the optimal reaction concentrations of phi29DNA Polymerase and T4 DNA Ligase were 0.17U / μL and 15U / μL, respectively, through electrochemical and agarose gel electrophoresis experiments. Under the optimal detection conditions, the sensor has a good linear response to the target miRNA-21 in the concentration range of 100aM to 100pM, with an LOD of 67aM, and the detection performance is better than that of previously reported detection methods. The sensor has good specificity and can identify RNA sequences with single-base mutations, and can be used for the detection of miRNA-21 in complex biological samples (cells, tissues and blood). The sensor has the ability to distinguish homologous miRNAs and has practical clinical application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Other features, objects and advantages of the present invention will become more apparent from the detailed description of non-limiting embodiments made with reference to the following drawings:
[0024] Figure 1 .Construction of an electrochemical biosensor based on the signal amplification strategy of target-triggered rolling circle amplification technology and its schematic diagram for detecting miRNA-21.
[0025] Figure 2 .(A) Agarose gel electrophoresis characterization of RCA reaction, M1: 50bp DNA Marker; Lane 1: miRNA-21; Lane 2: padlock probe; Lane 3: 1+2+T4 DNA Ligase+Reaction Buffer; Lane 4: 1+2+3+dNTPs+phi29DNA Polymerase+Reaction Buffer; M2: 15000bp DNA Marker; (B) DPV response signals of different modified electrodes.
[0026] Figure 3 .CV curves (A) and EIS curves (B, inset is the equivalent circuit diagram) of different modified electrodes.
[0027] Figure 4 .DPV response signals of electrodes modified with different probes.
[0028] Figure 5.(A, B) Agarose gel electrophoresis characterization of RCA reaction, M1: 50bp DNA Marker; Lane 1: miRNA-21; Lanes 2, 3: padlock probe and its RCA product; Lanes 4, 5: padlock probe A and its RCA product; Lanes 6, 7: padlock probe C and its RCA product; Lanes 8, 9: padlock probe G and its RCA product; DPV response signal (C) and DPV change rate (D), a: RCA blank product involving padlock probe A; b: RCA blank product involving padlock probe; c: RCA target product involving padlock probe A; d: RCA target product involving padlock probe.
[0029] Figure 6 .The effects of (A) padlock probe concentration and (B) RCA product assembly time on the electrode on the analytical performance of the sensor.
[0030] Figure 7 .(A) Effect of T4 DNA Ligase reaction time on the analytical performance of the sensor; (B) 1% agarose gel electrophoresis to characterize the effect of T4 DNA Ligase reaction time on ligation reaction and RCA reaction, M1: 50bp DNA Marker; Lane 1: miRNA-21; Lane 2: padlock probe; Lanes 3, 5, 7, 9, 11, and 13 are the ligation products of T4 DNA Ligase reaction at 16℃ for 0.5h, 1h, 1.5h, 2h, 2.5h, and 3h, respectively; Lanes 4, 6, 8, 10, 12, and 14 are the RCA products of T4 DNA Ligase reaction at 16℃ for 0.5h, 1h, 1.5h, 2h, 2.5h, and 3h, respectively; M2: 15000bp DNA Marker.
[0031] Figure 8 .(A) Effect of phi29 DNA Polymerase reaction concentration on the analytical performance of the sensor; (B) and (C) 1% agarose gel electrophoresis to characterize the effect of phi29 DNA Polymerase reaction concentration on RCA reaction, M1: 50bp DNA Marker; Lane 1: miRNA-21; Lane 2: padlock probe; Lane 3: ligation product of T4 DNA Ligase at 16℃ for 0.5h; (B) Lanes 4 and 5 are RCA products of 0.08U / μL and 0.17U / μL phi29 DNA Polymerase reaction concentrations, respectively; (C) Lanes 4, 5, 6, 7, and 8 are RCA products of 0.17U / μL, 0.33U / μL, 0.5U / μL, 0.67U / μL, and 0.83U / μL phi29 DNA Polymerase reaction concentrations, respectively, M2: 15000bp DNA Marker.
[0032] Fig. 9 .(A) Effect of T4 DNA Ligase reaction concentration on the analytical performance of the sensor; (B) 1% agarose gel electrophoresis to characterize the effect of T4 DNA Ligase reaction concentration on the ligation reaction and RCA reaction, M1: 50bp DNA Marker; Lane 1: miRNA-21; Lane 2: padlock probe; 5U / μL T4 DNA Ligase ligation product (lane 3) and its RCA product (lane 4); 10U / μL T4 DNA Ligase ligation product (lane 5) and its RCA product (lane 6); 15U / μL T4 DNA Ligase ligation product (lane 7) and its RCA product (lane 8); 20U / μL T4 DNA Ligase ligation product (lane 9) and its RCA product (lane 10); 25U / μL T4 DNA Ligase ligation product (lane 11) and its RCA product (lane 12); 30U / μL T4 DNA Ligase ligation product (lane 13) and RCA product (lane 14); M2: 15000 bp DNA Marker.
[0033] Fig.10 .(A) Fitting graph of the logarithm of miRNA-21 concentration and DPV change rate (the inset is the DPV curve); (B) Linear relationship graph of the sensor's response to miRNA-21.
[0034] Fig.11 .(A) DPV change rate diagram of different modified electrodes (the inset is the DPV curve diagram); (B) 1% agarose gel electrophoresis characterization of non-target sequences, target miRNA-21 and its RCA products, M1: 50bp DNA Marker; Lane 1: padlock probe; miRNA-122 (lane 2) and its RCA product (lane 3); miRNA-141 (lane 4) and its RCA product (lane 5); miRNA-199 (lane 6) and its RCA product (lane 7); miRNA-210 (lane 8) and its RCA product (lane 9); miRNA-21 (lane 10) and its RCA product (lane 11); M2: 15000bp DNA Marker. Fig.12.SmRNA I, smRNA II, dmRNA sequence mutation sites compared with miRNA-21 (A) and connection diagram (B). DPV curves of different modified electrodes (C) and their change rate diagram (D); (E) 1% agarose gel electrophoresis to characterize miRNA-21, smRNA I, smRNA II, dmRNA and their RCA products, M1: 50bp DNA Marker; Lane 1: padlock probe; miRNA-21 (lane 2) and its RCA product (lane 3); smRNA I (lane 4) and its RCA product (lane 5); smRNA II (lane 6) and its RCA product (lane 7); dmRNA (lane 8) and its RCA product (lane 9); M2: 15000bp DNA Marker.
[0035] Fig.13 .1.5% agarose electrophoresis was used to detect the extracted total cell RNA, lanes 1-3: HEK-293T cells; lanes 4-6: HeLa cells; lanes 7-9: MDA-MB-231 cells; lanes 10-12: HCC827 cells; lanes 13-15: A549 cells.
[0036] Fig.14 .RT-qPCR (A) and sensor (B) detection of miRNA-21 in cells. (*P<0.05, ***P<0.001)
[0037] Fig.15 .Photos of MDA-MB-231 (A), HCC827 (B), and A549 (C) tumor-bearing mice.
[0038] Fig.16 .(A) 1.5% agarose gel electrophoresis was used to detect the total RNA of the tumor tissues of the mice. Lanes 1-3: total RNA of tumor tissues of mice bearing MDA-MB-231 cells; Lanes 4-6: total RNA of tumor tissues of mice bearing HCC827 cells; Lanes 7-9: total RNA of tumor tissues of mice bearing A549 cells.
[0039] Fig.17 . RT-qPCR (A) and sensor (B) detection of miRNA-21 in mouse tumor tissues. (***P<0.001)
[0040] Fig.18 . RT-qPCR (A) and sensor (B) detection of miRNA-21 in clinical blood samples. DETAILED DESCRIPTION
[0041] The present invention uses the target miRNA-21 to trigger the RCA signal amplification strategy combined with magnetic separation technology to construct a new electrochemical biosensor for the detection of lung cancer marker miRNA-21 (the principle is shown in Figure 1 ). First, a padlock probe was designed with target miRNA-21 recognition sequences at both ends and a T-rich middle region. When miRNA-21 is present, the target recognition sequence in the padlock probe hybridizes with it, bringing the two ends of the probe close together. Next, T4 DNA Ligase was used to connect the two ends of the probe into a circular structure to form a circular template for the RCA reaction. Then, in the presence of phi29 DNA Polymerase and dNTPs, miRNA-21 was used as a primer to continuously trigger the RCA reaction, thereby generating a periodically repeated long-chain DNA product. Finally, the strong binding force between the A base in the long-chain DNA product and the gold electrode (AuE) was used to achieve efficient assembly of the RCA product on the AuE. The presence of the RCA product hinders the electron transfer on the AuE surface, causing the electrochemical signal to attenuate. The signal change can be monitored by differential pulse voltammetry (DPV) to indicate the concentration of miRNA-21. In addition, the feasibility, linear range, sensitivity and specificity of the sensor were investigated respectively, and it was further used for the quantitative detection of miRNA-21 in different human cell lines, mouse tumor tissues and blood samples of lung cancer patients. It was also compared with the gold standard RT-qPCR method to verify the practical applicability of the sensor.
[0042] The basic experimental operation methods involved in the present invention are described in 1-3 below.
[0043] 1. Sequences used in this experiment
[0044] The DNA and RNA sequences (HPLC purification) used in this study were synthesized and provided by Shanghai Shenggong Biotechnology Co., Ltd. The detailed sequences are shown in Table 1. In padlock probe, padlock probe A, padlock probe C, and padlock probe G, the underlined part is the template for synthesizing the sequence binding to the gold interface through RCA reaction, and the bold part is complementary to miRNA-21. In smRNA I, smRNA II, and dmRNA, the underlined part is the mutation site.
[0045] Table 1 DNA and RNA sequences used in this experiment
[0046]
[0047]
[0048] Among them, the "P" at the 5' end of the padlock probe represents phosphorylation modification. The 5' phosphate group and 3' hydroxyl group of the probe are connected to form a ring, thus becoming a ring-forming template for the RCA reaction; "MB" represents methylene blue labeling, and "biotin" represents biotin labeling.
[0049] 2. Preparation of RCA Amplification Products
[0050] The padlock probe circularization reaction was carried out in a 20 μL reaction system, which contained 1×T4 DNA Ligase Reaction Buffer, 1 μM padlock probe, and 10 nM target miRNA-21 (DEPC-H2O was used for the blank experiment). Before adding T4 DNA Ligase, the padlock probe, Ligase Reaction Buffer, and target miRNA-21 were mixed and denatured at 95°C for 5 min, incubated at 37°C for 30 min, and naturally cooled to room temperature after the reaction. During this process, the padlock probe was circularized under the action of target miRNA-21 and Buffer. Then, 30 U / μL T4 DNA Ligase was added, and the resulting mixture was incubated at 16°C for 3 h.
[0051] The rolling circle amplification reaction was carried out in a 30 μL system, which contained the above 20 μL ligation product, 1× phi29 DNA Polymerase Reaction Buffer, 0.83U / μL phi29 DNA Polymerase, 0.833mM dNTPsMix, and DEPC-H2O to 30 μL. The resulting mixture was incubated at 30°C for 60 minutes to carry out the rolling circle amplification reaction. After the reaction, the RCA amplification product was captured by magnetic beads for electrochemical sensor detection experiments, or directly verified by 1% agarose gel electrophoresis.
[0052] 3. Electrochemical sensor determination of target miRNA
[0053] Electrochemical detection was performed on the CHI660E electrochemical workstation of Shanghai Chenhua Instrument Co., Ltd. The electrochemical determination used a three-electrode system, with AuE as the working electrode, platinum wire electrode as the counter electrode, and Ag / AgCl as the reference electrode. At room temperature, the three-electrode system was immersed in the corresponding detection solution for electrochemical detection. The specific steps are as follows:
[0054] (1) Place the magnetic beads that have captured the RCA amplification product on a vortex oscillator for 20 seconds and vortex to resuspend the magnetic beads. Use a pipette to transfer 20 μL of magnetic beads to a new 1.5 mL centrifuge tube. Place the centrifuge tube on a magnetic separator and let it stand for 1 minute (this operation is referred to as magnetic separation in the following). Use a pipette to remove the supernatant and remove the centrifuge tube from the magnetic separator. (2) Add 200 μL of Buffer I to the centrifuge tube, cover the centrifuge tube cap, vortex thoroughly to resuspend the magnetic beads, perform magnetic separation, and discard the supernatant. (3) Repeat step (2) once. (4) Add 80 μL of Buffer I and 20 μL of 10 μM H1, vortex thoroughly to resuspend the magnetic beads, place the centrifuge tube in a rotating mixer, and rotate and mix at room temperature for 30 minutes. Perform magnetic separation and discard the supernatant. (5) Wash the magnetic beads three times according to the method in step (2). (6) The 60 μL system contains 30 μL 5×SSC (preparation method: mix 1.32 g NaCl and 0.66 g trisodium citrate dihydrate in a 50 mL centrifuge tube, fully dissolve with 30 mL DEPC-H2O, prepare 5×SSC buffer with pH 7.0, and store at 4°C), and 30 μL of the RCA amplification product prepared above. (The blank control group does not contain the target, and the other conditions are exactly the same as the experimental group). Rotate and mix for 30 minutes, discard the supernatant after magnetic separation, wash the precipitate twice with Buffer I, and discard the supernatant. (7) Add 10 μL DEPC-H2O, heat at 95°C for 2 minutes, immediately perform magnetic separation, collect the supernatant containing the target sequence into a new PCR tube, and then add 20 μL 5×SSC solution and mix well. (8) Take 5 μL of the solution obtained in step (7), add it dropwise to the activated AuE, incubate at room temperature for 30 minutes, and obtain the RCA amplification product / AuE. (9) The obtained electrode was measured by differential pulse voltammetry (DPV), electrochemical impedance spectroscopy, and cyclic voltammetry, respectively.
[0055] The differential pulse voltammetry (DPV) method is used to monitor the change of the response signal. The DPV change rate is expressed by ΔI%, and the calculation formula is: ΔI% = [(I0-I miRNA-21 ) / I0]×100%(1.2)
[0056] Where: I0 and I miRNA-21 Represent the DPV signals obtained from the sensor in the absence and presence of target miRNA-21, respectively.
[0057] 4. The method for constructing the nude mouse subcutaneous xenograft tumor model is as follows:
[0058] MDA-MB-231, HCC827, and A549 cells in the logarithmic growth phase were washed and digested, and then counted using a cell counter to adjust the cell concentration to 4 × 106 / μL. Use a syringe to take 100μL of the pre-adjusted cell suspension and inject it subcutaneously into healthy nude mice to form tumors. Use a vernier caliper to measure the size of the tumor. When the tumor size reaches 2cm×2cm×2cm, the next step can be performed.
[0059] Example 1 Feasibility Study of Sensor Strategy
[0060] In order to verify whether the padlock probe designed in the present invention can specifically recognize miRNA-21 and trigger the RCA reaction, 1% agarose gel electrophoresis was used to characterize the relevant experiments. Figure 2 As shown in Figure A, lane 1 is the band corresponding to miRNA-21; lane 2 is the padlock probe; lane 3 is the ligation product formed by the successful hybridization of miRNA-21 and the padlock probe under the action of T4 DNA ligase. Due to the increase in molecular weight, its swimming speed in the gel slows down, so the position of the band slightly moves up; the bright DNA spot observed in the spot well of lane 4 is the long-chain DNA product generated by the RCA reaction triggered by miRNA-21, which cannot swim downward due to its extremely large molecular weight. The results show that the padlock probe designed by the present invention can specifically recognize miRNA-21 and trigger the RCA reaction to produce a long-chain DNA product with a very large molecular weight, proving that the probe design is reasonable and feasible.
[0061] In order to verify whether the above RCA products can be assembled on AuE, differential pulse voltammetry (DPV) was used to characterize them. Figure 2 B shows that in the absence of miRNA-21, the DPV response current value of the reaction system incubated in AuE (38μA) is similar to that of AuE (40μA); in the presence of miRNA-21, the DPV response current of the reaction system assembled in AuE is 18μA. The results show that only when miRNA-21 is present can the RCA reaction be triggered and a large amount of RCA products be produced. When the product is assembled in AuE, it will hinder the electron transfer on the electrode surface and produce a significant DPV response signal.
[0062] In addition, the construction of the sensor was characterized by cyclic voltammetry (CV). Figure 3 In A, a pair of redox peaks of AuE can be observed. After AuE was assembled in the reaction system without miRN-21, the redox current was slightly reduced due to nonspecific adsorption. In the presence of miRNA-21, the RCA reaction was triggered to produce long-chain DNA products. After AuE was assembled, the electron transfer on the electrode surface was hindered, resulting in a significant decrease in the peak current. The results show that the RCA product formed by the amplification reaction triggered by miRNA-21 was successfully assembled on the electrode surface.
[0063] Electrochemical impedance spectroscopy (EIS) is an easy-to-operate electrochemical technique that can directly and effectively reflect the interfacial properties of modified electrodes by measuring electron transfer resistance and is used to characterize the assembly process of electrochemical biosensors. Figure 3 The inset of B shows the equivalent circuit, which consists of the solution resistance (R s ), double layer capacitance (C dl )、Warburg (diffusion) impedance (Z w ) and electron transfer resistance (R et ). Usually, the semicircle diameter of the EIS graph can approximately reflect the R et , which is widely used in the analysis of interactions between biomolecules. Figure 3 B shows that the R et The value is almost zero, indicating that it has good conductivity. After the reaction system without miRNA-21 assembled AuE, due to the adsorption of nonspecific substances on the AuE surface, R et The value increased to 800Ω. After the RCA products formed by the miRNA-21-induced reaction assembled AuE, R et The value increased significantly to 5000Ω, which indicates that the occurrence of RCA reaction produced a large amount of long-chain DNA, which, after being assembled on AuE, greatly hindered the [F(CN)6] 3- / 4- The above results demonstrate the successful construction of the electrochemical biosensor.
[0064] Example 2 Discussion of Sensing Mechanism
[0065] The A base has a stronger adsorption capacity on AuE than other bases, so this study designed a T-base-rich padlock probe and amplified the A-base-rich DNA product through the RCA reaction. In order to verify whether the A base plays an important role in the binding between the RCA product and AuE, methylene blue (MB)-labeled probes rich in A bases, T bases, C bases, and G bases were designed (see Table 1 for probe sequences) for experiments. The stronger the methylene blue signal, the more MB-labeled probes bind to the AuE surface. Figure 4 As shown in the figure, compared with naked AuE and AuE modified with blank buffer (1×SSC buffer), only the DPV response signal of the A-rich probe labeled with MB was significantly enhanced, while the DPV response signals of the T-, C- or G-rich probes did not change significantly. The results showed that the A base had the strongest binding force with the AuE surface.
[0066] In order to further verify the effect of base A on the fixation of RCA products on AuE, the padlock probe was modified. The padlock probe used in this study, designed padlock probe A, padlock probe C, and padlock probe G (sequence information see Table 1) were used for experiments, and the RCA amplification products generated were rich in base A, base T, base G, and base C, respectively. First, 1% agarose was used to characterize the padlock probes rich in four bases and their amplification products. Figure 5 As shown in A, lane 1 is the band corresponding to the target miRNA-21, lane 2 is the padlock probe used in this study, and the white bright spots appear in the spotting wells of lane 3 because miRNA-21 and the padlock probe undergo RCA reaction, producing RCA products with a molecular weight greater than 15,000 bp, which cannot effectively move in the gel and are thus retained in the spotting wells. The designed padlock probe A is clearly seen in lane 4, and the product formed by the RCA reaction in which it participates is also retained in the spotting wells (lane 5), but the band brightness is slightly lower than that of the band in lane 3, indicating that the amplification efficiency of its product is low. Padlock probe C (lane 7) and padlock probe G (lane 9) cannot undergo RCA reaction. It is speculated that the hybridization temperature and amplification temperature used in the experiment did not reach the required Tm value. The relevant temperature and experimental conditions will be optimized later to explore the reasons.
[0067] In addition, in order to make the concentrations of the amplified products of the padlock probe and padlock probe A consistent, the concentration of the target miRNA-21 was adjusted for RCA reaction. Figure 5 As shown in B, the band brightness of the RCA product rich in A base formed by the RCA reaction of the padlock probe (lane 3) and the RCA product rich in T base formed by the RCA reaction of the padlock probe A (lane 5) in the electrophoresis is consistent. At the same time, the UV ratio of the amplified product at 280nM and 260nM was tested by a UV spectrophotometer, and the electrochemical experiment was performed after the concentrations of the two were consistent. Figure 5 As shown in Figure C, the DPV peak current of the RCA product of padlock probe A without target involvement (curve a), with target involvement (curve c), and the DPV peak current of the RCA product of padlock probe A without target involvement (curve b) are all about 35μA, which is similar to the DPV peak current of AuE (37μA), while the DPV peak current of the RCA product formed by the padlock probe with target involvement is significantly reduced, about 18μA (curve d); in addition, only the RCA product formed by the padlock probe with target involvement has a significant DPV signal change rate (ΔI%=51%) after being assembled on AuE, and its signal change is 3 times that of the other three reaction systems ( Figure 5 D). The above results all indicate that the A-rich sequences formed by the RCA reaction do help the amplified product to bind to the AuE surface. Therefore, subsequent experiments will design T-rich padlock probes to participate in the RCA reaction.
[0068] Example 3 Optimization of experimental conditions
[0069] In order to achieve the best detection performance of the sensor, relevant experimental conditions were optimized, such as the concentration of the padlock probe and the assembly time of the RCA product.
[0070] 3.1 Optimization of padlock probe concentration
[0071] The RCA amplification product was prepared by referring to "2. Preparation of RCA amplification product", except that the concentration of the padlock probe was set to 1 μM (or 0.01 nM, or 0.1 nM, or 1 nM, or 10 nM, or 100 nM). The RCA product was detected by referring to the method of 3 electrochemical sensor for determining the target miRNA. The change of the response signal was monitored by differential pulse voltammetry (DPV).
[0072] like Figure 6 A shows that when the probe concentration is 0.01nM, ΔI% is about 17%, and ΔI% increases with the increase of concentration; when the probe concentration reaches 100nM, ΔI% tends to be stable and maintains at about 63%, indicating that when the padlock probe is 100nM, saturation is reached. Therefore, the optimal reaction concentration of the padlock probe is 100nM.
[0073] 3.2 Optimization of the assembly time of RCA products on electrodes
[0074] Refer to "2. Preparation of RCA amplification products" to prepare RCA amplification products. Refer to 3. Electrochemical sensor method for measuring target miRNA to detect RCA products. The difference is that in step (8), 5 μL of the solution obtained in step (7) is transferred and added dropwise to the activated AuE, and the prepared RCA product is incubated at room temperature for 15 min (or 20 min, or 30 min, or 45 min, or 60 min) to detect the prepared RCA product. Differential pulse voltammetry (DPV) is used to monitor the change of the response signal.
[0075] like Figure 6 As shown in Figure B, when the RCA product is assembled on the electrode for 15 minutes, its ΔI% is about 68%; when the assembly time is 20 minutes, ΔI% reaches a maximum value of 85%; as time increases, ΔI% continues to decrease, and when the assembly time is 60 minutes, ΔI% drops to 27%. The reason is that when the RCA product assembly time is too long, it will lead to a higher background value. Therefore, the optimal time for the RCA product to assemble on the electrode is 20 minutes.
[0076] 3.3Optimization of T4 DNA Ligase Reaction Time
[0077] The RCA amplification product was prepared by referring to "2. Preparation of RCA amplification product", except that in the step of T4 DNA Ligase, "30 U / μL T4 DNA Ligase was added, and the resulting mixture was incubated at 16°C for 0.5 h (or 1 h, or 1.5 h, or 2 h, or 2.5 h, or 3 h)"
[0078] The RCA product was detected by referring to the method of 3 electrochemical sensor for determining target miRNA. The change of response signal was monitored by differential pulse voltammetry (DPV). The prepared RCA product was detected by gel electrophoresis experiment on 1% agarose gel.
[0079] like Figure 7 A shows that ΔI% reaches a maximum of about 82% at 0.5h. As time goes by, ΔI% gradually decreases. After the reaction time reaches 1.5h, ΔI% tends to stabilize and remains at about 65%. To further verify this result, the inventors conducted experiments using 1% agarose gel electrophoresis. Figure 7 As shown in B, the corresponding bands when T4 DNA Ligase reacted for 0.5h (lane 4) and 1h (lane 6), the inventors observed that RCA products with extremely strong band brightness appeared in the spotting wells, and there was also a connection product band of about 100bp. As the reaction time was extended to 1.5h (lane 8), 2h (lane 10), 2.5h (lane 12), and 3h (lane 14), it was further observed that there were 3 bands in different positions in these lanes, namely, RCA products with a molecular weight greater than 15000bp in the gel wells, connection products with a molecular weight of about 100bp, and miscellaneous bands with a molecular weight of about 500bp. The inventors speculate that miscellaneous bands will also be assembled on AuE, increasing the background signal and leading to a decrease in ΔI%. Therefore, the optimal reaction time of T4 DNA Ligase is 0.5h.
[0080] 3.4 Optimization of phi29 DNA Polymerase Reaction Concentration
[0081] The RCA amplification product was prepared by referring to "2. Preparation of RCA amplification product", except that the concentration of phi29 DNA Polymerase in the rolling circle amplification reaction system was set to "0.08U / μL (or 0.17U / μL, or 0.33U / μL, or 0.5U / μL, or 0.67U / μL, or 0.83U / μL)". The RCA product was detected by referring to the method of 3 electrochemical sensor determination of target miRNA. The change of the response signal was monitored by differential pulse voltammetry (DPV).
[0082] At the same time, gel electrophoresis was used to detect the prepared RCA products on 1% agarose gel.
[0083] like Figure 8 As shown in A, when the reaction concentration of phi29 DNA Polymerase is 0.08U / μL, ΔI% is about 42%. As the enzyme concentration increases to 0.17U / μL, ΔI% tends to stabilize and maintains at about 80%. When the enzyme concentration continues to increase, ΔI% still does not change significantly. The results show that the optimal reaction concentration of phi29 DNA Polymerase is 0.17U / μL. At the same time, 1% agarose electrophoresis was used to further verify the results. As shown in 1.8B, the bands corresponding to lanes 1, 2, and 3 are the connection products of target miRNA-21, padlock probe, and T4 DNA Ligase reaction 0.5h, respectively. When the concentration of phi29 DNA Polymerase was 0.08U / μL, the RCA product (lane 4) band was darker. When the enzyme concentration increased to 0.17U / μL, the brightness of the RCA product (lane 5) band was significantly enhanced, indicating that when the enzyme concentration was 0.08U / μL, the RCA amplification reaction was not complete. When the concentration was 0.17U / μL, the RCA amplification reaction could be fully completed. Figure 8 The bands corresponding to lanes 1 to 3 in C are Figure 8 B, the figure shows that when the enzyme concentration is 0.17U / μL (lane 4), the band brightness of the RCA amplification product in the spot well is consistent with that when its concentration is 0.33 (lane 5), 0.5 (lane 6), 0.67 (lane 7), and 0.83 (lane 8) U / μL. The results also show that the optimal reaction concentration of phi29DNA Polymerase is 0.17U / μL.
[0084] Optimization of 3.5T4 DNA Ligase Reaction Concentration
[0085] The RCA amplification product was prepared by referring to "2. Preparation of RCA amplification product", except that the concentration of T4 DNA Ligase in the rolling circle amplification reaction system was set to 5U / μL (or 10U / μL, or 15U / μL, or 20U / μL, or 25U / μL, or 30U / μL)". The RCA product was detected by referring to the method of measuring target miRNA by electrochemical sensor 3. Differential pulse voltammetry (DPV) was used to monitor the change of response signal.
[0086] Gel electrophoresis was performed on 1% agarose gel to detect the prepared RCA products.
[0087] like Fig. 9As shown in A, when the reaction concentration is 5-15U / μL, ΔI% increases with the increase of enzyme concentration. When the enzyme concentration is 15U / μL, its value reaches the maximum. When the reaction concentration of T4 DNA Ligase is further increased, ΔI% tends to be stable and maintains at about 80%. Agarose gel electrophoresis was further used to verify the above results. Fig. 9 As shown in Figure B, as the enzyme concentration increases, the brightness of the RCA product in the spot well increases. When the enzyme concentration is 15U / μL, the brightness of the band corresponding to the RCA product (lane 8) is consistent with the brightness of the corresponding band in the spot well when the enzyme concentration increases to 20 (lane 10), 25 (lane 12), and 30 (lane 14) U / μL. This shows that the optimal reaction concentration of T4 DNA Ligase is 15U / μL.
[0088] Example 4 Analytical Performance of Sensor
[0089] 4.1 Sensor sensitivity investigation
[0090] The RCA amplification product was prepared by referring to "2. Preparation of RCA amplification product", except that the concentration of target miRNA-21 in the rolling circle amplification reaction system was set to "0pM (or 0.0001pM, or 0.001pM, or 0.01pM, or 0.1pM, or 1pM, or 10pM, or 100pM)". The RCA product was detected by referring to the method of measuring target miRNA by electrochemical sensor in 3. Differential pulse voltammetry (DPV) was used to monitor the change of response signal.
[0091] like Fig.10 As shown in the inset in A, the DPV response signal gradually decreases with the increase of miRNA-21 concentration, and in the concentration range of 0.0001 to 100 pM, the change rate of the current signal is proportional to the logarithm of the miRNA-21 concentration (logC [miRNA-21] ) shows a good linear relationship ( Fig.10 B), the linear regression equation is y = 66.2 + 10.2 × lg (C [miRNA-21] / pM ), R 2 =0.997, and the detection limit (LOD) is 67aM. This detection limit is significantly lower than many existing sensing detection methods, indicating that the constructed sensor has high sensitivity, which is mainly due to the RCA signal amplification strategy and the strong binding between the A base and AuE.
[0092] 4.2 Investigation of sensor specificity
[0093] Refer to "2. Preparation of RCA amplification products" to prepare RCA amplification products, except that the amplification template is set to "100fM target miRNA-21 (or 1pMmiRNA-122, or 1pMmiRNA-141, or 1pMmiRNA-199, or 1pMmiRNA-210, or 1pM smRNAI, or 1pM smRNAII, or 1pM dmRNA)". Refer to 3. The method for determining the target miRNA by electrochemical sensor is used to detect the RCA product. The change of the response signal is monitored by differential pulse voltammetry (DPV). Or directly use 1% agarose gel electrophoresis to verify the RCA amplification product.
[0094] like Fig.11 A shows that compared with the blank control, only the target miRNA-21 can produce a significant change in current response (ΔI% is about 60%), while other non-target sequences do not produce DPV current signal changes, proving that the sensor has a good recognition ability for the target miRNA-21. Subsequently, 1% agarose gel electrophoresis experiment was further used for verification. Fig.11 As shown in Figure B, no long-chain DNA products were observed in the spotting wells of lanes 3, 5, 7, and 9. This is because the padlock probe cannot recognize non-target miRNA-122 (lane 3), miRNA-141 (lane 5), miRNA-199 (lane 7), and miRNA-210 (lane 9), so it cannot trigger the RCA reaction to produce long-chain DNA products; while the long-chain DNA product band in the electrophoresis well of lane 11 is clearly visible, which is caused by the RCA reaction triggered by the target sequence miRNA-21. This once again proves that the biosensor has good selectivity for the target.
[0095] In addition, in order to further investigate the sensor's ability to recognize single and double bases, miRNA-21 sequences with single-base mutations (smRNA I, smRNA II) and miRNA-21 sequences with double-base mutations (dmRNA) were set up for electrochemical experiments (sequence information is shown in Table 1). Fig.12 A and B show the base mutation sites of the designed sequence and their connection schematic diagrams in the RCA reaction system. Fig.12 As shown in C and D, compared with the blank control, the DPV current response of the sensor to smRNA I and dmRNA did not change significantly. Although smRNA II caused a slight DPV response signal, it was still significantly lower than the response signal caused by the target miRNA-21. The results show that the sensor has excellent target recognition specificity and can even distinguish single-base mutation sequences. 1% agarose gel electrophoresis was also used to verify the electrochemical results. Fig.12As shown in Figure E, neither smRNA I nor dmRNA can trigger the RCA reaction (lane 5, lane 9). Although smRNA II can also cause the RCA reaction to generate amplification products and white bright spots appear in the spotting wells (lane 7), its band brightness is significantly lower than the RCA product generated by miRNA-21 (lane 3), indicating that its reaction efficiency is extremely low. The electrophoresis results are consistent with the electrochemical results, which once again proves that the sensor has good specificity.
[0096] Example 5 Detection capability of the sensor in biological samples
[0097] 5.1 Sensor detection of miRNA-21 expression level in cell samples
[0098] In order to verify the detection ability of the sensor in biological samples, the detection performance of the sensor for miRNA-21 in cell samples was investigated. First, total RNA was extracted from HEK-293T, HeLa, MDA-MB-231, HCC827, and A549 cells and the purity was analyzed. When the OD260 / 280 (R) value is between 1.8 and 2.0, it indicates that the extracted RNA has a high purity. Table 2 shows that the R values of the total RNA extracted from the five cells are all in the range of 1.8-2.0, indicating that they are of high purity. The purity of the above RNA was further verified by 1.5% agarose gel electrophoresis. Fig.13 As shown, three clear RNA bands appeared in the electrophoresis, corresponding to 28S, 18S and 5S RNA, respectively. The 5S band had the lowest brightness and the 28S had the highest brightness, further proving that the extracted total RNA had a high purity and could be used for subsequent experiments.
[0099] Table 2 Purity of total RNA extracted from cell lines
[0100]
[0101] According to literature reports, miRNA-21 is expressed at high levels in human cancer cell lines (such as HeLa, MDA-MB-231, HCC827, and A549), but at low levels in normal human cells (such as HEK-293T cells). First, the gold standard RT-qPCR technology currently used in clinical practice was used to evaluate the expression level of miRNA-21 in these cell lines. Fig.14 A shows the relative expression levels of miRNA-21 in different cell lines obtained by RT-qPCR analysis, which is consistent with previous reports. The developed sensor was used to further detect the expression level of miRNA-21. Fig.14B. It can be seen that the relative expression levels of miRNA-21 in these cell lines reflected by ΔI% are consistent with the results of RT-qPCR detection. The results show that the sensor has the ability to detect the expression levels of miRNA-21 in different cell lines.
[0102] 5.2 Sensor detection of miRNA-21 expression levels in different mouse tumor tissues
[0103] The inventors further investigated the sensor's ability to detect miRNA-21 in mouse tumor tissue. To this end, three tumor-bearing mouse models with different cells (MDA-MB-231, HCC827, and A549) were constructed. Fig.15 When the tumor tissue reached a certain size, total RNA was extracted and analyzed by OD260 / 280(R) value (Table 3) and 1.5% agarose gel electrophoresis ( Fig.16 ) was used for purity analysis. The results showed that the total RNA extracted from tumor tissue in this experiment had high purity and could be used for subsequent experiments.
[0104] Table 3 Purity of total RNA extracted from tumor tissues
[0105]
[0106] At the same time, RT-qPCR technology was used to detect the expression level of miRNA-21 in MDA-MB-231, HCC827 and A549 tumor tissues. The results showed that the expression levels increased in turn ( Fig.17 A), 150, 280 and 550 respectively, which is consistent with the results reported in the literature that miRNA-21 is highly expressed in breast cancer and lung cancer. The inventors further used the constructed sensor to detect the expression level of miRNA-21 in these tumor tissues ( Fig.17 B). The results showed that ΔI% was 50%, 68%, and 87%, respectively, indicating that miRNA-21 was also highly expressed in these tumor tissues, which was consistent with the gold standard RT-qPCR test results. In summary, the sensor developed by the present invention has the ability to detect the expression level of miRNA-21 in mouse tumor tissues.
[0107] 5.3 Sensor detection of miRNA-21 expression levels in clinical blood samples
[0108] It is reported that the expression level of miRNA-21 is upregulated in the peripheral blood of patients with non-small cell lung cancer (NSCLC). In order to further investigate the practical application performance of the sensor, the sensor was used to detect the expression level of miRNA-21 in the peripheral blood of 1 healthy person and 7 NSCLC patients. First, the RT-qPCR method was used to detect the extracted peripheral blood miRNAs. Fig.18As shown in A, the expression level of miRNA-21 in the peripheral blood of NSCLC is 7 to 20 times higher than that in healthy people. At the same time, the developed sensor was further used to detect the expression level of miRNA-21 in the above blood samples. Fig.18 B It can be seen that the relative expression level of miRNA-21 in the peripheral blood sample reflected by the DPV response signal change rate (ΔI%) is consistent with the relative expression detected by the RT-qPCR method. The results show that the sensor developed by the present invention has the ability to detect the expression level of miRNA-21 in the peripheral blood of clinical lung cancer patients.
[0109] The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention. It is obvious to those skilled in the art that the present invention is not limited to the details of the above exemplary embodiments, and the present invention can be implemented in other specific forms without departing from the spirit or basic features of the present invention. Therefore, no matter from which point of view, the embodiments should be regarded as exemplary and non-restrictive. The scope of the present invention is defined by the attached claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims are included in the present invention. Any figure mark in the claims should not be regarded as limiting the claims involved.
[0110] In addition, it should be understood that although this specification is described in terms of implementation methods, not every implementation method contains only one independent technical solution. This description method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment can also be appropriately combined to form other implementation methods that can be understood by those skilled in the art.
Claims
1. Pad probes for miRNA detection, It is characterized in that The probe contains two end regions and a middle region; the two end regions are a 5' end region and a 3' end region, the 5' end region contains a recognition sequence 1 of the target miRNA to be detected, and the 3' end region contains a recognition sequence 2 of the target miRNA to be detected; the middle region is rich in T bases; the recognition sequence 1 hybridizes with segment A of the miRNA to be detected, and the recognition sequence 2 hybridizes with segment B of the miRNA to be detected; the hybridization is complete hybridization or partial hybridization; and the segments A and B do not overlap.
2. The padlock probe according to claim 1, It is characterized in that The 3' end of segment A is closely connected to the 5' end of segment B or is separated by less than 5 nucleotides, or the 3' end of segment B is closely connected to the 5' end of segment A or is separated by less than 5 nucleotides; the separation of less than 5 nucleotides means a separation of 4, 3, 2, 1 or 0 nucleotides; preferably, the separation is 0 nucleotides.
3. The lock probe according to claim 1, It is characterized in that The lengths of the recognition sequence 1 and the recognition sequence 2 are 8-14 bp respectively; the lengths of the recognition sequence 1 and the recognition sequence 2 are the same or different; preferably, the lengths of the recognition sequence 1 and the recognition sequence 2 are 11 bp respectively.
4. The padlock probe according to claim 1, It is characterized in that The middle region contains 6-15 T bases; preferably, contains 10 T bases.
5. The padlock probe according to any one of claims 1 to 4, It is characterized in that The miRNA is miRNA-21; the sequence of the probe is shown in SEQ ID NO:
9.
6. Use of the padlock probe according to any one of claims 1 to 5 in the preparation of a cancer diagnostic product; preferably, the cancer has abnormal miRNA expression.
7. miRNA detection kit, It is characterized in that The kit comprises the padlock probe according to any one of claims 1 to 8; preferably, the kit further comprises a component selected from DNA ligase, DNA polymerase, dNTPs and miRNA; more preferably, the DNA ligase is T4 DNALigase, the DNA polymerase is phi29 DNAPolymerase, and the miRNA is miRNA-21.
8. A method for amplifying miRNA signals. It is characterized in that The method comprises the following steps: 1) hybridizing the padlock probe described in any one of claims 1 to 8 with miRNA to bring the two ends of the probe close together; 2) connecting the two ends of the probe into a circular structure using T4 DNA Ligase to form a circular template for the RCA reaction; 3) in the presence of phi29 DNA Polymerase and dNTPs, the miRNA acts as a primer to continuously trigger the RCA reaction, thereby generating a periodically repeated long-chain DNA product to achieve signal amplification.
9. Electrochemical biosensors for miRNA detection, It is characterized in that The sensor comprises a miRNA to be detected, a recognition element, a receptor, a transducer, and an electrochemical workstation; the recognition element is a padlock probe according to any one of claims 1 to 8; the receptor is a gold electrode; and the transducer is a computer.
